Publikationen 2015
Pfestroff A.
Somastostatinrezeptorszintigrafie
Der Nuklearmediziner 2015;Georg Thieme Verlag KG;DOI 10.1055/s-0034-139858738:56-61
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0034-1398587
Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S
Management
Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.
Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854274/
Pfestroff A, Luster M.
[How are thyroid nodules diagnosed?].
Dtsch Med Wochenschr. 2015 Apr;140(8):565-72. doi: 10.1055/s-0041-101539. Epub 2015 Apr 1. German.
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0041-101539
Willowson KP, Luster M, Tapner M; QUEST Investigator Team, Bailey DL.
A multicentre comparison of quantitative (90)Y PET/CT for dosimetric purposes after radioembolization with resin microspheres : The QUEST Phantom Study.
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1202-22. doi: 10.1007/s00259-015-3059-9. Epub 2015 May 13.
https://link.springer.com/article/10.1007%2Fs00259-015-3059-9
Treglia G, Trimboli P, Verburg FA, Luster M, Giovanella L.
Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule.
EurJ Clin Invest. 2015 Jul;45(7):739-44. doi: 10.1111/eci.12456. Epub 2015 Jun 1.
https://onlinelibrary.wiley.com/doi/full/10.1111/eci.12456
Verburg FA, Mäder U, Luster M, Hänscheid H, Reiners C.
Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancer.
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1390-8. doi: 10.1007/s00259-015-3076-8. Epub 2015 Jun 13.
https://link.springer.com/article/10.1007%2Fs00259-015-3076-8
Kletting P, Schimmel S, Hänscheid H, Luster M, Fernández M, Nosske D, Lassmann M, Glatting G.
The NUKDOS software for treatment planning in molecular radiotherapy.
Z Med Phys. 2015 Sep;25(3):264-74. doi:
https://www.sciencedirect.com/science/article/pii/S0939388915000021?via%3Dihub
Kletting P, Kull T, Maaß C, Malik N, Luster M, Beer A, Glatting G.
Optimized peptide amount and activity for Y-90-labeled DOTATATE therapy.
J Nucl Med. 2015 Dec 17. pii: jnumed.115.164699. [Epub ahead of print]
http://jnm.snmjournals.org/content/57/4/503.long
Mursina L, Groß V, Librizzi D, Luster M, Sohrabi A, Seifert O,
Hildebrandt O, Heverhagen JT, Koehler U, Sohrabi K.
[Pilot Project: Improved Lung Deposition via a New Nasal Inhalation Procedure].
Pneumologie. 2015 Aug;69(8):469-76. doi:10.1055/s-0034-1392444. Epub 2015 Aug 10. German.
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1392444
Pfestroff A, Luster M, Jilg CA, Olbert PJ, Ohlmann CH, Lassmann M, Maecke HR, Ezziddin S, Bodei L; Radionuclide Therapy Committee of the European Association of Nuclear Medicine.
Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks.
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1971-5. doi: 10.1007/s00259-015-3186-3.
No abstract available.
https://link.springer.com/article/10.1007%2Fs00259-015-3186-3
Maffioli L, Florimonte L, Costa DC, Correia Castanheira J, Grana C, Luster M, Bodei L, Chinol M.
New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer.
Q J Nucl Med Mol Imaging. 2015 Dec;59(4):420-38. Epub 2015 Jul 29.
https://www.minervamedica.it/en/journals/nuclear-med-molecular-imaging/article.php?cod=R39Y2015N04A0420
Luster M.
[Thyroid into the focus of attention].
Nuklearmedizin. 2015;54(3):75-6. German. No abstract available
Pfestroff A., Dietlein M., Luster M.
Nuklearmedizinische Diagnostik, Therapie und Nachsorge des Schilddrüsenkarzinoms
Onkologie 2015; Springer-Verlag .21:597-610.doi:10.1007/s00761-014-2859-z.
https://link.springer.com/article/10.1007/s00761-014-2859-z